Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Loidi JC, Cai Q, Cebrian Gallardo JJ, Dara M, Davidavičienė E, Forsman LD, De Los Rios Jefe J, Denholm J, Drakšienė J, Duarte R, Elamin SE, Salinas NE, Ferrarese M, Filippov A, Garcia A, García-García JM, Gaudiesiute I, Gavazova B, Gayoso R, Rosso RG, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Robles EM, Matteelli A, Mazza-Stalder J, Moschos C, Munoz-Torrico M, Hamdan HM, Nakčerienė B, Nicod L, Marcos MN, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quirós S, Rendon A, Saderi L, Šmite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB.

Eur Respir J. 2019 Oct 10. pii: 1901522. doi: 10.1183/13993003.01522-2019. [Epub ahead of print]

PMID:
31601711
2.

Tuberculosis among asylum-seekers in Milan, Italy: Epidemiological analysis and evaluation of interventions.

Villa S, Codecasa LR, Faccini M, Pontello MM, Ferrarese M, Castellotti PF, Senatore S, Lamberti A, Mazzola E, Perno CF, Campisi D, Saporiti M, Raviglione MC.

Eur Respir J. 2019 Aug 14. pii: 1900896. doi: 10.1183/13993003.00896-2019. [Epub ahead of print]

PMID:
31413161
3.

A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer.

Riccardi N, Ferrarese M, Castellotti P, Mazzola E, Sozzi F, Rigatti P, Vanzulli A, Sotgiu G, Codecasa L.

Urologia. 2019 Jul 4:391560319860396. doi: 10.1177/0391560319860396. [Epub ahead of print]

PMID:
31271544
4.

Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres.

Riccardi N, Alagna R, Saderi L, Ferrarese M, Castellotti P, Mazzola E, De Lorenzo S, Viggiani P, Udwadia Z, Besozzi G, Cirillo D, Sotgiu G, Codecasa L; for StopTB Italia Onlus Group.

BMC Infect Dis. 2019 Jun 28;19(1):564. doi: 10.1186/s12879-019-4211-0.

5.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

6.

Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges and future proposal.

Riccardi N, Alagna R, Motta I, Ferrarese M, Castellotti P, Nicolini LA, Diaw MM, Ndiaye M, Cirillo D, Codecasa L, Besozzi G.

Infect Dis (Lond). 2019 May;51(5):392-394. doi: 10.1080/23744235.2019.1572920. Epub 2019 Feb 18. No abstract available.

PMID:
30773087
7.

Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study.

Peri AM, Bernasconi DP, Galizzi N, Matteelli A, Codecasa L, Giorgio V, Di Biagio A, Franzetti F, Cingolani A, Gori A, Lapadula G.

BMC Infect Dis. 2018 Dec 20;18(1):690. doi: 10.1186/s12879-018-3609-4.

8.

Implementing TB control in a rural, resource-limited setting: the stop-TB Italia project in Senegal.

Diaw MM, Ndiaye M, Riccardi N, Ungaro R, Alagna R, Cirillo DM, Codecasa L, Viscoli C, Nicolini LA, Besozzi G; StopTB Italia Onlus.

Multidiscip Respir Med. 2018 Nov 9;13:41. doi: 10.1186/s40248-018-0154-3. eCollection 2018.

9.

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection.

Petruccioli E, Chiacchio T, Vanini V, Cuzzi G, Codecasa LR, Ferrarese M, Schininà V, Palmieri F, Ippolito G, Goletti D.

Sci Rep. 2018 Oct 23;8(1):15626. doi: 10.1038/s41598-018-33825-w.

10.

Haemoptysis and fever in a young refugee from Somalia.

Mondoni M, Viganò O, Ferrarese M, Bimbatti M, Cavallini M, Codecasa L, D'Arminio Monforte A, Bulfamante G, Centanni S, Sotgiu G.

Int J Infect Dis. 2018 Dec;77:57-60. doi: 10.1016/j.ijid.2018.10.002. Epub 2018 Oct 10. No abstract available.

11.

Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan.

Barcellini L, Campisi D, Castellotti PF, Cugnata F, Ferrara G, Ferrarese M, Murgia N, Repossi A, Cirillo DM, Codecasa LR.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1160-1165. doi: 10.5588/ijtld.18.0114.

PMID:
30236183
12.

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.

Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC.

PMID:
30216086
13.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

14.

Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.

Larsson LO, Polverino E, Hoefsloot W, Codecasa LR, Diel R, Jenkins SG, Loebinger MR.

Expert Rev Respir Med. 2017 Dec;11(12):977-989. doi: 10.1080/17476348.2017.1386563. Epub 2017 Oct 10. Review.

PMID:
28967797
15.

Long-lasting tuberculous pleurisy.

Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Codecasa LR, Ottenhoff TH, Denkinger CM, Goletti D.

Eur Respir J. 2017 May 25;49(5). pii: 1700356. doi: 10.1183/13993003.00356-2017. Print 2017 May. No abstract available.

16.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2017 May 21;49(5). pii: 1700387. doi: 10.1183/13993003.00387-2017. Print 2017 May.

17.

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.

Codecasa LR, Toumi M, D'Ausilio A, Aiello A, Damele F, Termini R, Uglietti A, Hettle R, Graziano G, De Lorenzo S.

J Mark Access Health Policy. 2017 Feb 17;5(1):1283105. doi: 10.1080/20016689.2017.1283105. eCollection 2017.

18.

Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis.

Faverio P, Stainer A, Bonaiti G, Zucchetti SC, Simonetta E, Lapadula G, Marruchella A, Gori A, Blasi F, Codecasa L, Pesci A, Chalmers JD, Loebinger MR, Aliberti S.

Int J Mol Sci. 2016 Nov 16;17(11). pii: E1913.

19.

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.

Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM.

Eur Respir J. 2016 Nov;48(5):1411-1419. doi: 10.1183/13993003.00510-2016. Epub 2016 Jul 7.

20.

Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey.

Bothamley GH, Ehlers C, Salonka I, Skrahina A, Orcau A, Codecasa LR, Ferrarese M, Pesut D, Solovic I, Dudnyk A, Anibarro L, Denkinger C, Guglielmetti L, Muylle I, Confalonieri M.

BMC Pregnancy Childbirth. 2016 Oct 12;16(1):304.

21.

Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.

Schepisi MS, Gualano G, Piselli P, Mazza M, D'Angelo D, Fasciani F, Barbieri A, Rocca G, Gnolfo F, Olivani P, Ferrarese M, Codecasa LR, Palmieri F, Girardi E.

Infect Dis Rep. 2016 Jun 24;8(2):6594. doi: 10.4081/idr.2016.6594. eCollection 2016 Jun 24.

22.

Lessons learnt from TB screening in closed immigration centres in Italy.

Crepet A, Repetto E, Al Rousan A, Sané Schepisi M, Girardi E, Prestileo T, Codecasa L, Garelli S, Corrao S, Ippolito G, Decroo T, Maccagno B.

Int Health. 2016 Sep;8(5):324-9. doi: 10.1093/inthealth/ihw025. Epub 2016 May 20.

23.

First independent evaluation of QuantiFERON-TB Plus performance.

Barcellini L, Borroni E, Brown J, Brunetti E, Codecasa L, Cugnata F, Dal Monte P, Di Serio C, Goletti D, Lombardi G, Lipman M, Rancoita PM, Tadolini M, Cirillo DM.

Eur Respir J. 2016 May;47(5):1587-90. doi: 10.1183/13993003.02033-2015. Epub 2016 Feb 11. No abstract available.

24.

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET.

Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84. doi: 10.1164/rccm.201502-0232OC.

PMID:
25763458
25.

Exogenous reinfection of tuberculosis in a low-burden area.

Schiroli C, Carugati M, Zanini F, Bandera A, Di Nardo Stuppino S, Monge E, Morosi M, Gori A, Matteelli A, Codecasa L, Franzetti F.

Infection. 2015 Dec;43(6):647-53. doi: 10.1007/s15010-015-0759-9. Epub 2015 Mar 10.

PMID:
25754899
26.

The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection.

Esposito S, Codecasa LR, Centis R.

Eur Respir J. 2015 Feb;45(2):571-4. doi: 10.1183/09031936.00157914. No abstract available.

27.

Tuberculosis-related stigma leading to an incomplete contact investigation in a low-incidence country.

Faccini M, Cantoni S, Ciconali G, Filipponi MT, Mainardi G, Marino AF, Senatore S, Codecasa LR, Ferrarese M, Gesu G, Mazzola E, Filia A.

Epidemiol Infect. 2015 Oct;143(13):2841-8. doi: 10.1017/S095026881400394X. Epub 2015 Jan 20.

PMID:
25600903
28.

Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal.

Codecasa LR, Ciconali G, Mazzola E, Ferrarese M, Cirillo D, Borroni E, Gesu GP, Zellweger JP, Centis R, Faccini M.

Eur Respir J. 2015 Jan;45(1):292-4. doi: 10.1183/09031936.00134114. No abstract available.

29.

Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis.

Norbis L, Alagna R, Tortoli E, Codecasa LR, Migliori GB, Cirillo DM.

Expert Rev Anti Infect Ther. 2014 May;12(5):633-47. doi: 10.1586/14787210.2014.899900. Epub 2014 Mar 20. Review.

PMID:
24717112
30.

Mycobacterium tuberculosis Beijing family: analysis of the epidemiological and clinical factors associated with an emerging lineage in the urban area of Milan.

Zanini F, Carugati M, Schiroli C, Lapadula G, Lombardi A, Codecasa L, Gori A, Franzetti F.

Infect Genet Evol. 2014 Jul;25:14-9. doi: 10.1016/j.meegid.2014.03.021. Epub 2014 Mar 30.

PMID:
24694826
31.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

32.

Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement.

van Hest NA, Aldridge RW, de Vries G, Sandgren A, Hauer B, Hayward A, Arrazola de Oñate W, Haas W, Codecasa LR, Caylà JA, Story A, Antoine D, Gori A, Quabeck L, Jonsson J, Wanlin M, Orcau Å, Rodes A, Dedicoat M, Antoun F, van Deutekom H, Keizer S, Abubakar I.

Euro Surveill. 2014 Mar 6;19(9). pii: 20728.

33.

The spread of drug-resistant tuberculosis in children: an Italian case series.

Mignone F, Codecasa LR, Scolfaro C, Raffaldi I, Lancella L, Ferrarese M, Garazzino S, Marabotto C, Esposito S, Gabiano C, Lipreri R, Tovo PA.

Epidemiol Infect. 2014 Oct;142(10):2049-56. doi: 10.1017/S0950268813003191. Epub 2013 Dec 19.

PMID:
24480079
34.

Influence of Hospitalization upon Diagnosis on the Risk of Tuberculosis Clustering.

Lapadula G, Zanini F, Codecasa L, Franzetti F, Ferrarese M, Carugati M, Mazzola E, Schiroli C, Motta D, Iemmi D, Gori A.

Mediterr J Hematol Infect Dis. 2013 Nov 20;5(1):e2013071. doi: 10.4084/MJHID.2013.071. eCollection 2013.

35.

The tubercular disease in immigrants without documents: new diagnostic settings adopted in Milan, Italy.

Olivani P, Codecasa L, Colucci A, Della Valle S, Mai L, Marceca M, Panizzut D, Sachsel E.

Ann Ig. 2013 Nov-Dec;25(6):493-500. doi: 10.7416/ai.2013.1949.

PMID:
24284535
36.

miRNA signatures in sera of patients with active pulmonary tuberculosis.

Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, Ambrosi A, Codecasa LR, Goletti D, Matteelli A, Ntinginya EN, Aloi F, Heinrich N, Reither K, Cirillo DM.

PLoS One. 2013 Nov 21;8(11):e80149. doi: 10.1371/journal.pone.0080149. eCollection 2013.

37.

Isoniazid preventive treatment: predictors of adverse events and treatment completion.

Codecasa LR, Murgia N, Ferrarese M, Delmastro M, Repossi AC, Casali L, Besozzi G, Ferrara G, Raviglione MC.

Int J Tuberc Lung Dis. 2013 Jul;17(7):903-8. doi: 10.5588/ijtld.12.0677. Epub 2013 May 3.

PMID:
23651743
38.

Tuberculosis outbreak in a primary school, Milan, Italy.

Faccini M, Codecasa LR, Ciconali G, Cammarata S, Borriello CR, De Gioia C, Za A, Marino AF, Vighi V, Ferrarese M, Gesu G, Mazzola E, Castaldi S.

Emerg Infect Dis. 2013 Mar;19(3):485-7. doi: 10.3201/eid1902.120527.

39.

[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers].

Murgia N, Ferrara G, Muzi G, Ferrarese M, Abbritti G, Codecasa LR.

G Ital Med Lav Ergon. 2011 Jul-Sep;33(3 Suppl):157-8. Italian.

PMID:
23393826
40.

Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.

Orlando G, Merli S, Cordier L, Mazza F, Casazza G, Villa AM, Codecasa L, Negri E, Cargnel A, Ferrarese M, Rizzardini G.

Infection. 2010 Jun;38(3):195-204. doi: 10.1007/s15010-010-0015-2. Epub 2010 Apr 22.

PMID:
20411295
41.

Differential diagnosis of cervical mycobacterial lymphadenitis in children.

Carvalho AC, Codecasa L, Pinsi G, Ferrarese M, Fornabaio C, Bergamaschi V, Lacchini C, Ekema G, Stefini S, Comelli M, Matteelli A.

Pediatr Infect Dis J. 2010 Jul;29(7):629-33. doi: 10.1097/INF.0b013e3181d1fdcd.

PMID:
20160660
42.

Genotyping analyses of tuberculosis transmission among immigrant residents in Italy.

Franzetti F, Codecasa L, Matteelli A, Degli Esposti A, Bandera A, Lacchini C, Lombardi A, Pinsi G, Zanini F, El-Hamad I, Gori A.

Clin Microbiol Infect. 2010 Aug;16(8):1149-54. doi: 10.1111/j.1469-0691.2009.03080.x. Epub 2009 Oct 14.

43.

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Codecasa LR, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group.

Eur Respir J. 2008 Apr;31(4):904-5. doi: 10.1183/09031936.00159807. No abstract available.

44.

Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infection.

Mantegani P, Piana F, Galli L, Scarpellini P, Codecasa L, Lazzarin A, Cirillo D, Fortis C.

New Microbiol. 2007 Jul;30(3):291-4.

45.

Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy.

Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, Thijsen S, Cirillo D, Ferrarese M, Greinert U, Fabbri LM, Richeldi L, Lange C; European Tuberculosis Network TBNET.

Eur Respir J. 2007 Dec;30(6):1173-9. Epub 2007 Aug 22.

46.

Clinical and operational value of the extensively drug-resistant tuberculosis definition.

Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group.

Eur Respir J. 2007 Oct;30(4):623-6. Epub 2007 Aug 9.

47.

Ripped from the headlines: how can we harness communications to control TB?

Migliori GB, Cirillo DM, Spanevello A, Codecasa LR; Stop TB Italia Group.

Eur Respir J. 2007 Aug;30(2):194-8. No abstract available.

48.

Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.

Piersimoni C, Lacchini C, Penati V, Iona E, Fattorini L, Nista D, Zallocco D, Gesu GP, Codecasa L.

Diagn Microbiol Infect Dis. 2007 Mar;57(3):283-7.

PMID:
17338942
49.

Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.

Mantegani P, Piana F, Codecasa L, Galli L, Scarpellini P, Lazzarin A, Cirillo D, Fortis C.

Clin Med Res. 2006 Dec;4(4):266-72.

50.

Supplemental Content

Loading ...
Support Center